Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Dyslipidemia

Free Subscription Articles published in Curr Opin Lipidol Retrieve available abstracts of 30 articles: HTML format Text format

Single Articles

August 2017
1. NEMES K, Aberg F
   Interpreting lipoproteins in nonalcoholic fatty liver disease.
   Curr Opin Lipidol. 2017;28:355-360.
   PubMed     Text format     Abstract available
   
   
   July 2017
2. BADIMON L, Padro T, Cubedo J
   Protein changes in non-LDL-lipoproteins in familial hypercholesterolemia: implications in cardiovascular disease manifestation and outcome.
   Curr Opin Lipidol. 2017 Jul 5. doi: 10.1097/MOL.0000000000000441.
   PubMed     Text format     Abstract available
   
   
   June 2017
3. PAALVAST Y, de Boer JF, Groen AK
   Developments in intestinal cholesterol transport and triglyceride absorption.
   Curr Opin Lipidol. 2017;28:248-254.
   PubMed     Text format     Abstract available
   
   
   April 2017
4. GRAHAM CA, Latten MJ, Hart PJ
   Molecular diagnosis of familial hypercholesterolaemia.
   Curr Opin Lipidol. 2017 Apr 29. doi: 10.1097/MOL.0000000000000430.
   PubMed     Text format     Abstract available
   
   
   
5. MARTIN AC, Bell DA, Brett T, Watts GF, et al
   Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies.
   Curr Opin Lipidol. 2017 Apr 19. doi: 10.1097/MOL.0000000000000423.
   PubMed     Text format     Abstract available
   
   
   
6. BURKE AC, Huff MW
   ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia.
   Curr Opin Lipidol. 2017;28:193-200.
   PubMed     Text format     Abstract available
   
   
   
7. ARSENAULT BJ, Perrot N, Couture P
   Does lifestyle contribute to disease severity in patients with inherited lipid disorders?
   Curr Opin Lipidol. 2017;28:177-185.
   PubMed     Text format     Abstract available
   
   
   March 2017
8. CALANDRA S, Tarugi P, Bertolini S
   Impact of rare variants in autosomal dominant hypercholesterolemia causing genes.
   Curr Opin Lipidol. 2017 Mar 18. doi: 10.1097/MOL.0000000000000414.
   PubMed     Text format     Abstract available
   
   
   February 2017
9. KINDT I, Mata P, Knowles JW
   The role of registries and genetic databases in familial hypercholesterolemia.
   Curr Opin Lipidol. 2017 Feb 6. doi: 10.1097/MOL.0000000000000398.
   PubMed     Text format     Abstract available
   
   
   
10. BOURBON M, Alves AC, Sijbrands EJ
    Low-density lipoprotein receptor mutational analysis in diagnosis of familial hypercholesterolemia.
    Curr Opin Lipidol. 2017 Feb 6. doi: 10.1097/MOL.0000000000000404.
    PubMed     Text format     Abstract available
    
    
    
11. HOPKINS PN, Lane SR
    Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns.
    Curr Opin Lipidol. 2017 Feb 2. doi: 10.1097/MOL.0000000000000397.
    PubMed     Text format     Abstract available
    
    
    
12. TAHER J, Farr S, Adeli K
    Central nervous system regulation of hepatic lipid and lipoprotein metabolism.
    Curr Opin Lipidol. 2017;28:32-38.
    PubMed     Text format     Abstract available
    
    
    
13. BJORNSON E, Adiels M, Taskinen MR, Boren J, et al
    Kinetics of plasma triglycerides in abdominal obesity.
    Curr Opin Lipidol. 2017;28:11-18.
    PubMed     Text format     Abstract available
    
    
    January 2017
14. SANTOS RD
    Phenotype vs. genotype in severe familial hypercholesterolemia: what matters most for the clinician?
    Curr Opin Lipidol. 2017 Jan 5. doi: 10.1097/MOL.0000000000000391.
    PubMed     Text format     Abstract available
    
    
    December 2016
15. HOPKINS PN
    Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening.
    Curr Opin Lipidol. 2016 Dec 24. doi: 10.1097/MOL.0000000000000388.
    PubMed     Text format     Abstract available
    
    
    
16. NORMAN R, Watts GF, Weintraub W, Gidding SS, et al
    Challenges in the health economics of familial hypercholesterolemia.
    Curr Opin Lipidol. 2016;27:563-569.
    PubMed     Text format     Abstract available
    
    
    
17. KOCKX M, Kritharides L
    Hyperlipidaemia in immunosuppression.
    Curr Opin Lipidol. 2016;27:631-632.
    PubMed     Text format    
    
    
    August 2016
18. HARALAMBOS K, Ashfield-Watt P, McDowell IF
    Diagnostic scoring for familial hypercholesterolaemia in practice.
    Curr Opin Lipidol. 2016;27:367-374.
    PubMed     Text format     Abstract available
    
    
    April 2016
19. GENCER B, Nanchen D
    Identifying familial hypercholesterolemia in acute coronary syndrome.
    Curr Opin Lipidol. 2016.
    PubMed     Text format     Abstract available
    
    
    
20. BOGSRUD MP, Ulven SM, Holven KB
    Does intrauterine exposure to hypercholesterolemia adversely affect familial hypercholesterolemia phenotype?
    Curr Opin Lipidol. 2016.
    PubMed     Text format     Abstract available
    
    
    
21. MUNDAL L, Retterstol K
    A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries.
    Curr Opin Lipidol. 2016.
    PubMed     Text format     Abstract available
    
    
    
22. HIGGINS CA, Rees A
    Do the mechanisms by which LDL-c levels are reduced influence the extent of clinical benefit which subsequently accrues?
    Curr Opin Lipidol. 2016;27:207-8.
    PubMed     Text format    
    
    
    
23. STENDER S, Tybjaerg-Hansen A
    Using human genetics to predict the effects and side-effects of drugs.
    Curr Opin Lipidol. 2016;27:105-11.
    PubMed     Text format     Abstract available
    
    
    
24. GHAZALPOUR A, Cespedes I, Bennett BJ, Allayee H, et al
    Expanding role of gut microbiota in lipid metabolism.
    Curr Opin Lipidol. 2016;27:141-7.
    PubMed     Text format     Abstract available
    
    
    
25. GAUDET D
    Novel therapies for severe dyslipidemia originating from human genetics.
    Curr Opin Lipidol. 2016;27:112-24.
    PubMed     Text format     Abstract available
    
    
    February 2016
26. FARR S, Taher J, Adeli K
    Central nervous system regulation of intestinal lipid and lipoprotein metabolism.
    Curr Opin Lipidol. 2016;27:1-7.
    PubMed     Text format     Abstract available
    
    
    December 2015
27. BRAHM AJ, Hegele RA
    Combined hyperlipidemia: familial but not (usually) monogenic.
    Curr Opin Lipidol. 2015.
    PubMed     Text format     Abstract available
    
    
    
28. SIJBRANDS EJ, Nieman K, Budoff MJ
    Cardiac computed tomography imaging in familial hypercholesterolaemia: implications for therapy and clinical trials.
    Curr Opin Lipidol. 2015;26:586-92.
    PubMed     Text format     Abstract available
    
    
    
29. GRYN SE, Hegele RA
    Novel therapeutics in hypertriglyceridemia.
    Curr Opin Lipidol. 2015;26:484-91.
    PubMed     Text format     Abstract available
    
    
    
30. WIERZBICKI AS, Watts GF
    The hinterland of familial hypercholesterolaemia: what do we not know?
    Curr Opin Lipidol. 2015;26:475-83.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: